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Abstract
The presentation of juvenile psoriatic arthritis (JPsA) has long been recognized to be clinically heterogeneous. As the
deﬁnition of JPsA expanded to accommodate atypical manifestations of psoriasis in young children, studies began to reﬂect an
increasingly clear biphasic distribution of age of onset, with peaks in the ﬁrst few years of life and again in early adolescence.
These two subpopulations differ in gender ratio, pattern of joint involvement, laboratory ﬁndings and potentially response to
therapy. Intriguingly, a similar distribution of age of onset has been observed in juvenile rheumatoid arthritis (JRA), and
correlates with patterns of HLA association. While a secure classiﬁcation of subpopulations within JPsA awaits improved
pathophysiologic understanding, future research must consider the possibility that different disease mechanisms may be
operative in distinct subsets of patients with this disorder.
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The diagnosis of juvenile rheumatic conditions has
been hampered by the lack of a biological gold
standard, thus necessitating phenotypic characteriza-
tion of different subclasses of arthritis. While existing
classiﬁcation schemes treat JPsA as a single entity,
substantial heterogeneity within this group has been
noted (Southwood et al. 1989; Petty et al. 2004;
Southwood and Petty 2005). Several case series have
noted two separate peaks of onset, one within the ﬁrst
few years of life and another in later childhood, raising
the possibility that JPsA may actually contain more
than one clinical subpopulation (Lambert et al. 1976;
Southwood et al. 1989; Stoll et al. 2006). This
distinction is important with respect to investigations
into the etiology and treatment of this condition.
Herein we summarize the data on this issue.
The ﬁrst documented cases of psoriasis coexisting
with arthritis were published by Ansell and Bywaters
(1962), in their brief description of 7 children initially
diagnosed with JRA who subsequently developed
psoriatic skin lesions. The ﬁrst formal case report of
JPsA was published in 1973 by Angevine et al. (1973)
detailing a child with psoriasis since the age of three
who developed arthritis involving his ankles and small
joints of the hands and feet. This report was followed
shortly by a case series of 43 children with JPsA, co-
authored by Lambert et al. (1976). Observing that
arthritis preceded psoriasis in approximately half the
cases (Table I), often by several years, these authors
expanded the deﬁnition of JPsA to include any child
witharthritiswhodevelopedpsoriasisatanytimeupto
15 years after the onset of arthritis.
Another important ﬁnding in the Lambert study
was that the age of onset curve appeared to have two
peaks. While mean age of onset was 9.3 years, more
than 80% of children developed arthritis either before
the age of six or after the age of ten. A comparable
biphasic age of onset was observed by Truckenbrodt
and Hafner (1990) using a similar case deﬁnition.
Complementing these ﬁndings, Ansell et al. (1993)
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with JPsA differed between those presenting before
age 6 and those that presented later in childhood.
Subsequent clinical series of patients with JPsA
remained consistent with the observations of Lambert
et al. (1976), noting a mean age of onset of 10–12
years of age, generally older than in populations of
patients with JRA (Table I) (Calabro 1977; Sills 1980;
Shore and Ansell 1982; Hamilton et al. 1990;
Truckenbrodt and Hafner 1990). All of these studies
conﬁrmed the ﬁndings of Lambert et al. that arthritis
preceded psoriasis in a substantial proportion of
patients (23–58%), often by several years (Table I).
These ﬁndings prompted several authors to suggest
that criteria should be developed to entertain the
diagnosis of JPsA in the absence of psoriasis (Sills
1980; Shore and Ansell 1982).
Southwood et al. (1989), answered the call for more
inclusive criteria for JPsA, introducing what became
known as the Vancouver criteria. These criteria
deﬁned deﬁnite JPsA as arthritis occurring with
psoriasis or, in its absence, with at least three of four
minor criteria, including dactylitis, nail pitting, family
history in a ﬁrst or second degree relative, or a rash
(present by history or on exam) that resembles
psoriasis but is not conclusively diagnosed as such.
Probable JPsA was diagnosed as arthritis without
psoriasis, but with exactly two of the minor criteria.
In this study, Southwood et al. identiﬁed 35 patients
with JPsA (24 deﬁnite, of whom 21 had psoriasis),
reporting a mean age of onset considerably younger
than in all of the previous reports (6.7 years). This
younger mean age may have reﬂected an increased
ability to detect younger patients, in whom psoriatic
skin lesions are often subtle or atypical (Cassidy and
Petty 2005). Accordingly, they noted an even more
pronounced bimodal distribution, with an early peak
(age 0–2) comprised largely of girls, and a later peak
(age 12–14) evenly mixed between boys and girls.
Notably, using the Lambert criteria, Shore and Ansell
(1982) had also noted an earlier age of onset in girls.
In support of the notion of JPsA sine frank psoriasis,
Southwood et al. (1989) reported that the 11 patients
with probable JPsA were similar to the 24 with deﬁnite
JPsA with respect to the patterns of affected joints.
The Vancouver criteria were validated by Roberton
et al. (1996), in a study of 63 children with JPsA, of
whom 50 had deﬁnite JPsA. As with the Southwood
study, patients with probable and deﬁnite JPsA had
similar joints involved at onset and throughout the
course of the disease. The population as a whole had
a relatively young age of onset of 5.9 years, again
consistent with the possibility that including children
with more subtle manifestations of the psoriatic
diathesis allows for the identiﬁcation of a population
of young patients in addition to the somewhat older
children reported in earlier series.
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M. L. Stoll & P. A. Nigrovic 378Using a relatively large cohort of JPsA patients, we
set out to study the possibility that younger and older
children with JPsA constitute clinically distinct
subgroups. We studied 139 children meeting the
Vancouver criteria and collected information on joint
involvement, laboratory results, and treatment
decisions at each visit for each patient (Stoll et al.
2006). We found an age of onset distribution similar to
that previously reported, with two peaks: one in early
childhood and the other near adolescence, optimally
divided at age 5 (Figure 1). The size of our sample
enabled us to search for clinical or laboratory
differences between older and younger children.
Indeed these were quite striking: young children
were more likely to be female (76 vs. 50%), to have
dactylitis (63 vs. 22%) and polyarticular onset (20 vs.
6%), and to be ANA positive (64 vs. 37%), but were
less likely to have frank psoriasis (14 vs. 31%),
enthesitis (22 vs. 57%), or axial disease (10 vs. 26%)
(p all ,0.05) (Stoll et al. 2006). Cluster analysis on
the 117 (84%) of patients for whom we had complete
data also generated two distinct subgroups that
differed by age and the above clinical and laboratory
variables; interestingly, however, age of onset was a
less reliable predictor of clinical phenotype than was
the presence of dactylitis, which was present in 100%
of the younger cluster (n ¼ 40) vs. 1.3% of the older
cluster (n ¼ 77) (p , 0.001) (Stoll et al. 2006). Thus
it remains uncertain whether the critical variable
determining phenotype in JPsA is truly age or whether
age is better regarded as a marker for a particular
subset of disease, e.g. arthritis accompanied by
dactylitis.
The signiﬁcance of these dual populations remains
uncertain. Very similar general patterns of onset
have been observed within JRA, with a peak around
age 2–3 years composed predominantly of girls and a
second distribution through mid- and late-childhood
where the gender distribution is somewhat more
balanced (Sullivan et al. 1975; Murray et al. 1999).
Analysis of HLA expression has also reﬂected a
striking variation in allele frequency with age of onset,
occasionally in a gender-speciﬁc fashion and com-
monly with a suggestion of an inﬂection point around
age 5–6 years (Murray et al. 1999). It has been
hypothesized that early onset arthritis could reﬂect the
inﬂuence of endemic infections of childhood (Martini
2003). Indeed, the limited “window of effect” of each
HLA allele — the age range during which the allele
is associated with an increased or decreased risk of
juvenile arthritis — would be consistent with a model
in which disease is triggered by antigenic exposures
that vary with the age of the child (Murrayet al. 1999).
Our ﬁnding that age of onset predicts clinical
phenotype of JPsA suggests a similar hypothesis of
differential susceptibility to environmental exposures,
especially given earlier data indicating differences in
HLA distribution between younger and older children
with JPsA (Ansell et al. 1993; Stoll et al. 2006). It is
especially intriguing that the early childhood peak
in JRA coincides with that of JPsA, despite clear
differences in clinical phenotype, including presence
of dactylitis, distribution of joint involvement, and
tendency toward a systemic inﬂammatory state in
young patients with JPsA (Huemer et al. 2002; Stoll
et al. 2006). This result could suggest an effect of
similar age-related exposures such as infections and
vaccinations, or potentially a temporally delimited
susceptibility within the synovium or enthesis.
An alternate possibility is suggested by the
identiﬁcation by cluster analysis of dactylitis as the
best predictor of clinical pattern within our JPsA
cohort (Stoll et al. 2006). Dactylitis describes the
diffuse swelling of a single digit characteristic of
psoriatic arthritis, and may reﬂect the sum of small
joint arthritis, periostitis, tenosynovitis and enthesitis
(Olivieri et al. 1996; Kane et al. 1999; Benjamin and
McGonagle 2001). While more frequent among
younger children, dactylitis was observed among
patients of all ages. To the extent that the propensity
to develop dactylitis derives from a particular set of
pathogenic mechanisms, it could be that the most
informative subgrouping of JPsA rests on the presence
of this clinical feature rather than the age of onset. If
so, then the age of onset curves would likely reﬂect the
net result of unknown biologic and environmental
factors promoting forms of psoriatic arthritis with and
without dactylitis. Such an approach would have the
additional appeal of enabling the search for continuity
between pediatric and adult psoriatic arthritis,
currently divided by convention at the 16th birthday
(Southwood et al. 1989; Petty et al. 2004).
In conclusion, our work has substantiated and
extended earlier ﬁndings that JPsA is a diverse disease.
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Figure 1. Age of onset of 139 children with JPsA diagnosed under
the Vancouver criteria. Evaluation of multiple cutoffs between the
younger and older distributions reveals optimal division at ,5 years
vs. 5 years and above; the resulting two distributions do not deviate
signiﬁcantly from normal as assessed by the Lillefors-corrected
Kolmogorov-Smirnoff test. Reprinted with permission (pending)
from Stoll et al. (2006).
A review of the literature 379We ﬁnd that these patients may be divided into two
subsets according to age of onset, although other
clinicalfeaturessuchasthepresenceofdactylitismight
also serve as organizing principles. The signiﬁcance of
these ﬁndings for pathogenesis and therapy of JPsA
remains uncertain, yet it is clear that future research
needs to avoid the assumption that children with JPsA
constitute a single homogenous population.
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